1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Journal article

Peer reviewed

J. Shen, R. Pachynski, L.T. Nordquist, N. Adra, M.A. Bilen, R. Aggarwal, Z. Reichert, M. Schweizer, A. Iravani, S. Aung, …

Annals of oncology, Vol.34, pp.S974-S975

10/2023

Files and links (1)

url

https://doi.org/10.1016/j.annonc.2023.09.2752View

Published (Version of record) Open

1 Record Views

Title: 1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Creators: J. Shen - UCLA Jonsson Comprehensive Cancer Center
R. Pachynski - Washington University in St. Louis
L.T. Nordquist - Urology Cancer Center and GU Research Network
N. Adra - Indiana University Health
M.A. Bilen - Emory University
R. Aggarwal - University of California, San Francisco
Z. Reichert - University of Michigan
M. Schweizer - University of Washington Medical Center
A. Iravani - University of Washington
S. Aung - Ambrx (United States)
C. Hessel - Ambrx (United States)
S.T. Tagawa - Cornell University
Publication Details: Annals of oncology, Vol.34, pp.S974-S975
Publisher: Elsevier Ltd
Identifiers: 991006262525202656
Academic Unit: Radiology
Language: English
Resource Type: Journal article